The GPI-anchoring of PrP Implications in sorting and pathogenesis

Prion

Volumn 8, Issue 1, 2014, Pages

  Puig, Berta ^a   Altmeppen, Hermann ^a   Glatzel, Markus ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

GPI anchor; Lipid rafts; Prion diseases; Prion protein; Processing; PrP; Signaling

Indexed keywords

GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN; MEMBRANE PROTEIN; OLIGOMER; PRION PROTEIN; SIALIC ACID; SIGNAL PEPTIDE; GLYCOSYLPHOSPHATIDYLINOSITOL; ISOPROTEIN;

CELL MEMBRANE; CELLULAR DISTRIBUTION; CONFORMATIONAL TRANSITION; DEGENERATIVE DISEASE; INTRACELLULAR SPACE; LIPID COMPOSITION; LIPID RAFT; NEUROTOXICITY; NONHUMAN; PATHOGENESIS; POINT MUTATION; PRION DISEASE; PROTEIN CONFORMATION; PROTEIN DEGRADATION; PROTEIN LOCALIZATION; REVIEW; SIGNAL TRANSDUCTION; METABOLISM; PROTEIN TRANSPORT;

GLYCOSYLPHOSPHATIDYLINOSITOLS; PROTEIN ISOFORMS; PROTEIN TRANSPORT; PROTEOLYSIS; PRPC PROTEINS; SIGNAL TRANSDUCTION;

EID: 84896928901     PISSN: 19336896     EISSN: 1933690X     Source Type: Journal    
DOI: 10.4161/pri.27892     Document Type: Review

References (119)

1. Rudd PM, Merry AH, Wormald MR, Dwek RA. Glycosylation and prion protein. Curr Opin Struct Biol2002; 12:578-86; PMID:12464308; http://dx.doi.org/10.1016/ S0959-440X(02)00377-9 (Pubitemid 35449064)
2. Stahl N, Baldwin MA, Teplow DB, Hood L, Gibson BW, Burlingame AL, Prusiner SB. Structural studies of the scrapie prion protein using mass spectrometry and amino acid sequencing. Biochemistry1993; 32:1991-2002; PMID:8448158; http://dx.doi.org/10.1021/bi00059a016 (Pubitemid 23086050)
3. Prusiner SB. Prions.Proc Natl Acad Sci U S A1998; 95:13363-83; PMID:9811807; http://dx.doi.org/10.1073/pnas.95.23.13363 (Pubitemid 28525623)
4. Fujita M, Kinoshita T. Structural remodeling of GPI anchors during biosynthesis and after attachment to proteins.FEBS Lett2010; 584:1670-7; PMID:19883648; http://dx.doi.org/10.1016/j. febslet.2009.10.079
5. Ferguson MAJ, Kinoshita T, Hart GW. Glycosylphosphatidylinositol Anchors. 2nd ed. Cold Spring Harbor: Cold Spring Harbor Laboratory Press; 2009. Chapter 11
6. Paulick MG, Bertozzi CR. The glycosylphosphatidylinositol anchor: a complex membrane-anchoring structure for proteins.Biochemistry2008; 47:6991-7000; PMID:18557633; http://dx.doi.org/10.1021/ bi8006324 (Pubitemid 351956348)
7. Orlean P, Menon AK. Thematic review series: lipid posttranslational modifications. GPI anchoring of protein in yeast and mammalian cells, or: how we learned to stop worrying and love glycophospholipids.J Lipid Res2007; 48:993-1011; PMID:17361015; http://dx.doi.org/10.1194/jlr.R700002-JLR200
8. Morandat S, Bortolato M, Roux B. Role of GPIanchored enzyme in liposome detergent-resistance.J Membr Biol2003; 191:215-21; PMID:12571756; http://dx.doi.org/10.1007/s00232-002-1056-y (Pubitemid 37011482)
9. Barboni E, Rivero BP, George AJ, Martin SR, Renoup DV, Hounsell EF, Barber PC, Morris RJ. The glycophosphatidylinositol anchor affects the conformation of Thy-1 protein.J Cell Sci1995; 108:487-97; PMID:7539435
10. Kukulansky T, Abramovitch S, Hollander N. Cleavage of the glycosylphosphatidylinositol anchor affects the reactivity of thy-1 with antibodies.J Immunol1999; 162:5993-7; PMID:10229838 (Pubitemid 29314956)
11. Legler DF, Doucey MA, Schneider P, Chapatte L, Bender FC, Bron C. Differential insertion of GPIanchored GFPs into lipid rafts of live cells.FASEB J2005; 19:73-5; PMID:15516372 (Pubitemid 40069922)
12. Medof ME, Nagarajan S, Tykocinski ML. Cell-surface engineering with GPI-anchored proteins.FASEB J1996; 10:574-86; PMID:8621057 (Pubitemid 26141169)
13. Liu T, Li R, Pan T, Liu D, Petersen RB, Wong BS, Gambetti P, Sy MS. Intercellular transfer of the cellular prion protein.J Biol Chem2002; 277:47671-8; PMID:12359724; http://dx.doi.org/10.1074/jbc. M207458200
14. Vidugiriene J, Menon AK. The GPI anchor of cell-surface proteins is synthesized on the cytoplasmic face of the endoplasmic reticulum.J Cell Biol1994; 127:333-41; PMID:7929579; http://dx.doi.org/10.1083/ jcb.127.2.333 (Pubitemid 24313724)
15. Brewis IA, Ferguson MA, Mehlert A, Turner AJ, Hooper NM. Structures of the glycosyl-phosphatidylinositol anchors of porcine and human renal membrane dipeptidase. Comprehensive structural studies on the porcine anchor and interspecies comparison of the glycan core structures.J Biol Chem1995; 270:22946-56; PMID:7559431; http://dx.doi.org/10.1074/jbc.270.39.22946
16. Meri S, Lehto T, Sutton CW, Tyynelä J, Baumann M. Structural composition and functional characterization of soluble CD59: heterogeneity of the oligosaccharide and glycophosphoinositol (GPI) anchor revealed by laser-desorption mass spectrometric analysis. Biochem J1996; 316:923-35; PMID:8670172
17. Stahl N, Baldwin MA, Burlingame AL, Prusiner SB. Identification of glycoinositol phospholipid linked and truncated forms of the scrapie prion protein. Biochemistry1990; 29:8879-84; PMID:1980209; http://dx.doi.org/10.1021/ bi00490a001 (Pubitemid 20311960)
18. Baldwin MA. Analysis of glycosylphosphatidylinositol protein anchors: the prion protein.Methods Enzymol2005; 405:172-87; PMID:16413315; http://dx.doi.org/10.1016/S0076-6879(05)05008-1
19. Simons K, Sampaio JL. Membrane organization and lipid rafts.Cold Spring Harb Perspect Biol2011; 3:a004697; PMID:21628426; http://dx.doi.org/10.1101/ cshperspect.a004697
20. Udenfriend S, Kodukula K. How glycosylphosphatidylinositol- anchored membrane proteins are made.Annu Rev Biochem1995; 64:563-91; PMID:7574493; http://dx.doi.org/10.1146/annurev. bi.64.070195.003023
21. Fujita M, Jigami Y. Lipid remodeling of GPI-anchored proteins and its function.Biochim Biophys Acta2008; 1780:410-20; PMID:17913366; http://dx.doi.org/10.1016/j.bbagen.2007.08.009 (Pubitemid 351381242)
22. Lingwood D, Simons K. Lipid rafts as a membraneorganizing principle.Science2010; 327:46-50; PMID:20044567; http://dx.doi.org/10.1126/ science.1174621
23. Tsui-Pierchala BA, Encinas M, Milbrandt J, Johnson EMJr.Lipid rafts in neuronal signaling and function.Trends Neurosci2002; 25:412-7; PMID:12127758; http://dx.doi.org/10.1016/ S0166-2236(02)02215-4
24. Stefanová I, Horejsí V, Ansotegui IJ, Knapp W, Stockinger H. GPI-anchored cell-surface molecules complexed to protein tyrosine kinases.Science1991; 254:1016-9; PMID:1719635; http://dx.doi.org/10.1126/ science.1719635 (Pubitemid 21917433)
25. Chen Y, Veracini L, Benistant C, Jacobson K. The transmembrane protein CBP plays a role in transiently anchoring small clusters of Thy-1, a GPIanchored protein, to the cytoskeleton.J Cell Sci2009; 122:3966-72; PMID:19825940; http://dx.doi.org/10.1242/jcs.049346
26. de Hoop MJ, Dotti CG. Membrane traffic in polarized neurons in culture.J Cell Sci Suppl1993; 17:85-92; PMID:8144707; http://dx.doi.org/10.1242/ jcs.1993.Supplement-17.13 (Pubitemid 24041284)
27. van Meer G, Simons K. Lipid polarity and sorting in epithelial cells.J Cell Biochem1988; 36:51-8; PMID:3277985; http://dx.doi.org/10.1002/ jcb.240360106
28. Brown DA, Crise B, Rose JK. Mechanism of membrane anchoring affects polarized expression of two proteins in MDCK cells.Science1989; 245:1499-501; PMID:2571189; http://dx.doi.org/10.1126/ science.2571189 (Pubitemid 19243241)
29. Lisanti MP, Caras IW, Davitz MA, Rodriguez- Boulan E. A glycophospholipid membrane anchor acts as an apical targeting signal in polarized epithelial cells.J Cell Biol1989; 109:2145-56; PMID:2478564; http://dx.doi.org/10.1083/jcb. 109.5.2145 (Pubitemid 19282603)
30. Sarnataro D, Paladino S, Campana V, Grassi J, Nitsch L, Zurzolo C. Pr PC is sorted to the basolateral membrane of epithelial cells independently of its association with rafts.Traffic2002; 3:810-21; PMID:12383347; http://dx.doi.org/10.1034/j.1600-0854.2002.31106.x (Pubitemid 35277007)
31. Paladino S, Sarnataro D, Pillich R, Tivodar S, Nitsch L, Zurzolo C. Protein oligomerization modulates raft partitioning and apical sorting of GPI-anchored proteins.J Cell Biol2004; 167:699-709; PMID:15557121; http://dx.doi.org/10.1083/ jcb.200407094 (Pubitemid 39565150)
32. Paladino S, Lebreton S, Tivodar S, Campana V, Tempre R, Zurzolo C. Different GPI-attachment signals affect the oligomerisation of GPI-anchored proteins and their apical sorting.J Cell Sci2008; 121:4001-7; PMID:19056670; http://dx.doi.org/10.1242/jcs.036038
33. Puig B, Altmeppen HC, Thurm D, Geissen M, Conrad C, Braulke T, Glatzel M. N-glycans and glycosylphosphatidylinositol- anchor act on polarized sorting of mouse Pr P(C) in Madin-Darby canine kidney cells.PLo S One2011; 6:e24624; PMID:21931781; http://dx.doi.org/10.1371/journal.pone.0024624
34. Madore N, Smith KL, Graham CH, Jen A, Brady K, Hall S, Morris R. Functionally different GPI proteins are organized in different domains on the neuronal surface.EMBO J1999; 18:6917-26; PMID:10601014; http://dx.doi.org/10. 1093/emboj/18.24.6917 (Pubitemid 30000445)
35. Brügger B, Graham C, Leibrecht I, Mombelli E, Jen A, Wieland F, Morris R. The membrane domains occupied by glycosylphosphatidylinositol-anchored prion protein and Thy-1 differ in lipid composition.J Biol Chem2004; 279:7530-6; PMID:14660659; http://dx.doi.org/10.1074/jbc.M310207200 (Pubitemid 38294631)
36. Tivodar S, Paladino S, Pillich R, Prinetti A, Chigorno V, van Meer G, Sonnino S, Zurzolo C. Analysis of detergent-resistant membranes associated with apical and basolateral GPI-anchored proteins in polarized epithelial cells.FEBS Lett2006; 580:5705-12; PMID:17007841; http://dx.doi.org/10.1016/j. febslet.2006.09.022 (Pubitemid 44515092)
37. Mironov AJr., Latawiec D, Wille H, Bouzamondo- Bernstein E, Legname G, Williamson RA, Burton D, De Armond SJ, Prusiner SB, Peters PJ. Cytosolic prion protein in neurons.J Neurosci2003; 23:7183-93; PMID:12904479 (Pubitemid 36975883)
38. Galvan C, Camoletto PG, Dotti CG, Aguzzi A, Ledesma MD. Proper axonal distribution of Pr P(C) depends on cholesterol-sphingomyelin-enriched membrane domains and is developmentally regulated in hippocampal neurons.Mol Cell Neurosci2005; 30:304-15; PMID:16139509; http://dx.doi.org/10.1016/j.mcn.2005.07. 003 (Pubitemid 41416550)
39. Chen R, Knez JJ, Merrick WC, Medof ME. Comparative efficiencies of C-terminal signals of native glycophosphatidylinositol (GPI)-anchored proproteins in conferring GPI-anchoring.J Cell Biochem2001; 84:68-83; PMID:11746517; http:// dx.doi.org/10.1002/jcb.1267 (Pubitemid 33101512)
40. Nicholson TB, Stanners CP. Specific inhibition of GPI-anchored protein function by homing and selfassociation of specific GPI anchors.J Cell Biol2006; 175:647-59; PMID:17101695; http://dx.doi.org/10.1083/jcb.200605001 (Pubitemid 44790617)
41. Nicholson TB, Stanners CP. Identification of a novel functional specificity signal within the GPI anchor signal sequence of carcinoembryonic antigen.J Cell Biol2007; 177:211-8; PMID:17438079; http:// dx.doi.org/10.1083/ jcb.200701158 (Pubitemid 46658633)
42. Wadsworth JD, Hill AF, Beck JA, Collinge J. Molecular and clinical classification of human prion disease.Br Med Bull2003; 66:241-54; PMID:14522862; http:// dx.doi.org/10.1093/bmb/66.1.241 (Pubitemid 37173505)
43. Gu Y, Singh A, Bose S, Singh N. Pathogenic mutations in the glycosylphosphatidylinositol signal peptide of Pr P modulate its topology in neuroblastoma cells.Mol Cell Neurosci2008; 37:647-56; PMID:18325785; http://dx.doi.org/10.1016/j.mcn.2007.08.018
44. Guizzunti G, Zurzolo C. The fate of Pr P GPI-anchor signal peptide is modulated by P238S pathogenic mutation.Traffic2014; 15:78-93; PMID:24112521; http://dx.doi.org/10.1111/tra.12126
45. Borchelt DR, Taraboulos A, Prusiner SB. Evidence for synthesis of scrapie prion proteins in the endocytic pathway.J Biol Chem1992; 267:16188-99; PMID:1353761
46. Béranger F, Mangé A, Goud B, Lehmann S. Stimulation of Pr P(C) retrograde transport toward the endoplasmic reticulum increases accumulation of Pr P(Sc) in prion-infected cells.J Biol Chem2002; 277:38972-7; PMID:12163492; http://dx.doi.org/10.1074/jbc.M205110200
47. Marijanovic Z, Caputo A, Campana V, Zurzolo C. Identification of an intracellular site of prion conversion.PLo SPathog2009; 5:e1000426; PMID:19424437; http://dx.doi.org/10.1371/journal. ppat.1000426
48. Baron GS, Wehrly K, Dorward DW, Chesebro B, Caughey B. Conversion of raft associated prion protein to the protease-resistant state requires insertion of Pr P-res (Pr P(Sc)) into contiguous membranes. EMBO J2002; 21:1031-40; PMID:11867531; http:// dx.doi.org/10.1093/emboj/21.5.1031 (Pubitemid 34206176)
49. Goold R, Rabbanian S, Sutton L, Andre R, Arora P, Moonga J, Clarke AR, Schiavo G, Jat P, Collinge J, et al.Rapid cell-surface prion protein conversion revealed using a novel cell system.Nat Commun2011; 2:281; PMID:21505437; http://dx.doi.org/10.1038/ ncomms1282
50. Goold R, Mc Kinnon C, Rabbanian S, Collinge J, Schiavo G, Tabrizi SJ. Alternative fates of newly formed Pr PSc upon prion conversion on the plasma membrane.J Cell Sci2013; 126:3552-62; PMID:23813960; http://dx.doi.org/10.1242/ jcs.120477
51. Taraboulos A, Scott M, Semenov A, Avrahami D, Laszlo L, Prusiner SB. Cholesterol depletion and modification of COOH-terminal targeting sequence of the prion protein inhibit formation of the scrapie isoform.J Cell Biol1995; 129:121-32; PMID:7698979; http:// dx.doi.org/10.1083/jcb.129.1.121
52. Mangé A, Nishida N, Milhavet O, Mc Mahon HE, Casanova D, Lehmann S. Amphotericin B inhibits the generation of the scrapie isoform of the prion protein in infected cultures.J Virol2000; 74:3135-40; PMID:10708429; http://dx.doi.org/10.1128/ JVI.74.7.3135-3140.2000 (Pubitemid 30143737)
53. Marella M, Lehmann S, Grassi J, Chabry J. Filipin prevents pathological prion protein accumulation by reducing endocytosis and inducing cellular Pr P release.J Biol Chem2002; 277:25457-64; PMID:11994310; http://dx.doi.org/10.1074/ jbc. M203248200 (Pubitemid 34951859)
54. Taraboulos A, Scott M, Semenov A, Avrahami D, Laszlo L, Prusiner SB. Cholesterol depletion and modification of COOH-terminal targeting sequence of the prion protein inhibit formation of the scrapie isoform.J Cell Biol1995; 129:121-32; PMID:7698979; http:// dx.doi.org/10.1083/jcb.129.1.121
55. Kocisko DA, Come JH, Priola SA, Chesebro B, Raymond GJ, Lansbury PT, Caughey B. Cell-free formation of protease-resistant prion protein. Nature1994; 370:471-4; PMID:7913989; http:// dx.doi.org/10.1038/370471a0 (Pubitemid 24263553)
56. Mc Nally KL, Ward AE, Priola SA. Cells expressing anchorless prion protein are resistant to scrapie infection.J Virol2009; 83:4469-75; PMID:19225008; http://dx.doi.org/10.1128/ JVI.02412-08
57. Priola SA, Mc Nally KL. The role of the prion protein membrane anchor in prion infection.Prion2009; 3:134-8; PMID:19786843; http://dx.doi.org/10.4161/ pri.3.3.9771
58. Speare JO, Offerdahl DK, Hasenkrug A, Carmody AB, Baron GS. GPI anchoring facilitates propagation and spread of misfolded Sup35 aggregates in mammalian cells.EMBO J2010; 29:782-94; PMID:20057357; http://dx.doi.org/10.1038/emboj. 2009.392
59. Fernández-Borges N, Chianini F, Eraña H, Vidal E, Eaton SL, Pintado B, Finlayson J, Dagleish MP, Castilla J. Naturally prion resistant mammals: a utopia?Prion2012; 6:425-9; PMID:22954650; http://dx.doi.org/10.4161/ pri.22057
60. Nisbet RM, Harrison CF, Lawson VA, Masters CL, Cappai R, Hill AF.Residues surrounding the glycosylphosphatidylinositol anchor attachment site of Pr P modulate prion infection: insight from the resistance of rabbits to prion disease.J Virol2010; 84:6678-86; PMID:20427543; http://dx.doi.org/10.1128/ JVI.02709-09
61. Jeffrey M, Mc Govern G, Sisó S, González L. Cellular and sub-cellular pathology of animal prion diseases: relationship between morphological changes, accumulation of abnormal prion protein and clinical disease.Acta Neuropathol2011; 121:113-34; PMID:20532540; http://dx.doi.org/10. 1007/ s00401-010-0700-3
62. Büeler H, Aguzzi A, Sailer A, Greiner RA, Autenried P, Aguet M, Weissmann C. Mice devoid of Pr P are resistant to scrapie.Cell1993; 73:1339-47; PMID:8100741; http://dx.doi.org/10.1016/0092-8674(93)90360-3 (Pubitemid 23201147)
63. Mallucci G, Dickinson A, Linehan J, Klöhn PC, Brandner S, Collinge J. Depleting neuronal Pr P in prion infection prevents disease and reverses spongiosis. Science2003; 302:871-4; PMID:14593181; http://dx.doi.org/10.1126/ science.1090187 (Pubitemid 37339628)
64. Sandberg MK, Al-Doujaily H, Sharps B, Clarke AR, Collinge J. Prion propagation and toxicity in vivo occur in two distinct mechanistic phases. Nature2011; 470:540-2; PMID:21350487; http:// dx.doi.org/10.1038/nature09768
65. Chesebro B, Race B, Meade-White K, Lacasse R, Race R, Klingeborn M, Striebel J, Dorward D, Mc Govern G, Jeffrey M. Fatal transmissible amyloid encephalopathy: a new type of prion disease associated with lack of prion protein membrane anchoring. PLo SPathog2010; 6:e1000800; PMID:20221436; http://dx.doi.org/10.1371/journal.ppat.1000800
66. Fasano C, Campana V, Zurzolo C. Prions: protein only or something more? Overview of potential prion cofactors.J Mol Neurosci2006; 29:195-214; PMID:17085779; http://dx.doi.org/10.1385/ JMN:29:3:195 (Pubitemid 44684495)
67. Taylor DR, Whitehouse IJ, Hooper NM.Glypican-1 mediates both prion protein lipid raft association and disease isoform formation.PLo SPathog2009; 5:e1000666; PMID:19936054; http://dx.doi.org/10.1371/journal.ppat.1000666
68. Fivaz M, Vilbois F, Thurnheer S, Pasquali C, Abrami L, Bickel PE, Parton RG, van der Goot FG. Differential sorting and fate of endocytosed GPIanchored proteins.EMBO J2002; 21:3989-4000; PMID:12145200; http://dx.doi.org/10.1093/ emboj/ cdf398 (Pubitemid 34857432)
69. Sunyach C, Jen A, Deng J, Fitzgerald KT, Frobert Y, Grassi J, Mc Caffrey MW, Morris R. The mechanism of internalization of glycosylphosphatidylinositolanchored prion protein.EMBO J2003; 22:3591-601; PMID:12853474; http://dx.doi.org/10.1093/emboj/ cdg344 (Pubitemid 36898336)
70. Taylor DR, Hooper NM. The low-density lipoprotein receptor-related protein 1 (LRP1) mediates the endocytosis of the cellular prion protein.Biochem J2007; 402:17-23; PMID:17155929; http://dx.doi.org/10.1042/BJ20061736
71. Parkyn CJ, Vermeulen EG, Mootoosamy RC, Sunyach C, Jacobsen C, Oxvig C, Moestrup S, Liu Q, Bu G, Jen A, et al.LRP1 controls biosynthetic and endocytic trafficking of neuronal prion protein.J Cell Sci2008; 121:773-83; PMID:18285446; http:// dx.doi.org/10.1242/jcs.021816 (Pubitemid 351578113)
72. Sarnataro D, Caputo A, Casanova P, Puri C, Paladino S, Tivodar SS, Campana V, Tacchetti C, Zurzolo C. Lipid rafts and clathrin cooperate in the internalization of Pr P in epithelial FRT cells.PLo S One2009; 4:e5829; PMID:19503793; http://dx.doi.org/10.1371/journal. pone.0005829
73. Linden R, Martins VR, Prado MA, Cammarota M, Izquierdo I, Brentani RR. Physiology of the prion protein. Physiol Rev2008; 88:673-728; PMID:18391177; http://dx.doi.org/10.1152/physrev.00007.2007 (Pubitemid 351520090)
74. Biasini E, Turnbaugh JA, Unterberger U, Harris DA. Prion protein at the crossroads of physiology and disease.Trends Neurosci2012; 35:92-103; PMID:22137337; http://dx.doi.org/10.1016/j. tins.2011.10.002
75. Bate C, Williams A. Role of glycosylphosphatidylinositols in the activation of phospholipase A2 and the neurotoxicity of prions.J Gen Virol2004; 85:3797-804; PMID:15557253; http://dx.doi.org/10.1099/ vir.0.80366-0 (Pubitemid 39591887)
76. Bate C, Tayebi M, Williams A. Phospholipase A2 inhibitors protect against prion and Abeta mediated synapse degeneration.Mol Neurodegener2010; 5:13; PMID:20374666; http://dx.doi.org/10.1186/1750-1326-5-13
77. Brown WJ, Chambers K, Doody A. Phospholipase A2 (PLA2) enzymes in membrane trafficking: mediators of membrane shape and function.Traffic2003; 4:214-21; PMID:12694560; http://dx.doi.org/10.1034/j.1600-0854.2003.00078.x (Pubitemid 36665382)
78. Bate C, Williams A. Neurodegeneration induced by clustering of sialylatedglycosylphosphatidylinositols of prion proteins.J Biol Chem2012; 287:7935-44; PMID:22262833; http://dx.doi.org/10.1074/jbc. M111.275743
79. Bate C, Williams A. Monoacylated cellular prion protein modifies cell membranes, inhibits cell signaling, and reduces prion formation.J Biol Chem2011; 286:8752-8; PMID:21212283; http://dx.doi.org/10.1074/jbc.M110.186833
80. Bate C, Williams A. The cellular prion protein with a monoacylatedglycosylphosphatidylinositol anchor modifies cell membranes, inhibits cell signaling and reduces prion formation.Prion2011; 5:65-8; PMID:21738009; http://dx.doi.org/10.4161/ pri.5.2.16095
81. Khosravani H, Zhang Y, Tsutsui S, Hameed S, Altier C, Hamid J, Chen L, Villemaire M, Ali Z, Jirik FR, et al. Prion protein attenuates excitotoxicity by inhibiting NMDA receptors.J Cell Biol2008; 181:551-65; PMID:18443219; http://dx.doi.org/10.1083/ jcb.200711002
82. Wang YT, Salter MW. Regulation of NMDA receptors by tyrosine kinases and phosphatases.Nature1994; 369:233-5; PMID:7514272; http://dx.doi.org/10.1038/ 369233a0 (Pubitemid 24154800)
83. Salter MW, Kalia LV. Src kinases: a hub for NMDA receptor regulation.Nat Rev Neurosci2004; 5:317-28; PMID:15034556; http://dx.doi.org/10.1038/ nrn1368 (Pubitemid 38478658)
84. Swanwick CC, Shapiro ME, Yi Z, Chang K, Wenthold RJ. NMDA receptors interact with flotillin- 1 and -2, lipid raft-associated proteins.FEBS Lett2009; 583:1226-30; PMID:19298817; http:// dx.doi.org/10.1016/j.febslet.2009.03.017
85. Ponce J, de la Ossa NP, Hurtado O, Millan M, Arenillas JF, Dávalos A, Gasull T. Simvastatin reduces the association of NMDA receptors to lipid rafts: a cholesterol-mediated effect in neuroprotection. Stroke2008; 39:1269-75; PMID:18323503; http:// dx.doi.org/10.1161/STROKEAHA.107.498923 (Pubitemid 351440701)
86. Mouillet-Richard S, Ermonval M, Chebassier C, Laplanche JL, Lehmann S, Launay JM, Kellermann O. Signal transduction through prion protein. Science2000; 289:1925-8; PMID:10988071; http:// dx.doi.org/10.1126/science.289.5486.1925
87. Laurén J, Gimbel DA, Nygaard HB, Gilbert JW, Strittmatter SM. Cellular prion protein mediates impairment of synaptic plasticity by amyloid- beta oligomers.Nature2009; 457:1128-32; PMID:19242475; http://dx.doi.org/10. 1038/ nature07761
88. Um JW, Nygaard HB, Heiss JK, Kostylev MA, Stagi M, Vortmeyer A, Wisniewski T, Gunther EC, Strittmatter SM. Alzheimer amyloid-? oligomer bound to postsynaptic prion protein activates Fyn to impair neurons.Nat Neurosci2012; 15:1227-35; PMID:22820466; http://dx.doi.org/10.1038/ nn.3178
89. Um JW, Strittmatter SM. Amyloid-? induced signaling by cellular prion protein and Fyn kinase in Alzheimer disease.Prion2013; 7:37-41; PMID:22987042; http://dx.doi.org/10.4161/pri.22212
90. Larson ME, LesnéSE. Soluble A oligomer production and toxicity.J Neurochem2012; 120(Suppl 1):125-39; PMID:22121920; http://dx.doi.org/10.1111/j. 1471-4159.2011.07478.x
91. Resenberger UK, Harmeier A, Woerner AC, Goodman JL, Müller V, Krishnan R, Vabulas RM, Kretzschmar HA, Lindquist S, Hartl FU, et al.The cellular prion protein mediates neurotoxic signalling of -sheet-rich conformers independent of prion replication. EMBO J2011; 30:2057-70; PMID:21441896; http://dx.doi.org/10.1038/emboj.2011.86
92. Pradines E, Hernandez-Rapp J, Villa-Diaz A, Dakowski C, Ardila-Osorio H, Haik S, Schneider B, Launay JM, Kellermann O, Torres JM, et al.Pathogenic prions deviate Pr P(C) signaling in neuronal cells and impair A-beta clearance.Cell Death Dis2013; 4:e456; PMID:23303130; http://dx.doi.org/10.1038/ cddis.2012.195
93. Rambold AS, Müller V, Ron U, Ben-Tal N, Winklhofer KF, Tatzelt J. Stress-protective signalling of prion protein is corrupted by scrapie prions.EMBO J2008; 27:1974-84; PMID:18566584; http://dx.doi.org/10.1038/emboj. 2008.122
94. Chen SG, Teplow DB, Parchi P, Teller JK, Gambetti P, Autilio-Gambetti L. Truncated forms of the human prion protein in normal brain and in prion diseases.J Biol Chem1995; 270:19173-80; PMID:7642585; http://dx.doi.org/10.1074/ jbc.270.32.19173
95. Taylor DR, Parkin ET, Cocklin SL, Ault JR, Ashcroft AE, Turner AJ, Hooper NM. Role of ADAMs in the ectodomain shedding and conformational conversion of the prion protein.J Biol Chem2009; 284:22590-600; PMID:19564338; http://dx.doi.org/10.1074/jbc.M109.032599
96. Altmeppen HC, Prox J, Puig B, Kluth MA, Bernreuther C, Thurm D, Jorissen E, Petrowitz B, Bartsch U, De Strooper B, et al.Lack of a-disintegrin- and-metalloproteinase ADAM10 leads to intracellular accumulation and loss of shedding of the cellular prion protein in vivo.Mol Neurodegener2011; 6:36; PMID:21619641; http://dx.doi.org/10.1186/1750-1326-6-36
97. Sunyach C, Cisse MA, da Costa CA, Vincent B, Checler F. The C-terminal products of cellular prion protein processing, C1 and C2, exert distinct influence on p53-dependent staurosporine-induced caspase- 3 activation.J Biol Chem2007; 282:1956-63; PMID:17121821; http://dx.doi.org/10.1074/jbc. M609663200 (Pubitemid 47076732)
98. Westergard L, Turnbaugh JA, Harris DA. A naturally occurring C-terminal fragment of the prion protein (Pr P) delays disease and acts as a dominant-negative inhibitor of Pr PSc formation.J Biol Chem2011; 286:44234-42; PMID:22025612; http://dx.doi.org/10.1074/jbc.M111.286195
99. Altmeppen HC, Prox J, Puig B, Dohler F, Falker C, Krasemann S, Glatzel M. Roles of endoproteolytic -cleavage and shedding of the prion protein in neurodegeneration.FEBS J2013; 280:4338-47; PMID:23413979; http://dx.doi.org/10. 1111/ febs.12196
100. Meier P, Genoud N, Prinz M, Maissen M, Rülicke T, Zurbriggen A, Raeber AJ, Aguzzi A. Soluble dimeric prion protein binds Pr P(Sc) in vivo and antagonizes prion disease.Cell2003; 113:49-60; PMID:12679034; http://dx.doi.org/10.1016/ S0092-8674(03)00201-0 (Pubitemid 36411959)
101. Guillot-Sestier MV, Sunyach C, Druon C, Scarzello S, Checler F. The alpha-secretase-derived N-terminal product of cellular prion, N1, displays neuroprotective function in vitro and in vivo.J Biol Chem2009; 284:35973-86; PMID:19850936; http://dx.doi.org/10.1074/jbc.M109.051086
102. Guillot-Sestier MV, Checler F. -Secretase-derived cleavage of cellular prion yields biologically active catabolites with distinct functions. Neurodegener Dis2012; 10:294-7; PMID:22261541; http://dx.doi.org/10.1159/ 000333804
103. Calella AM, Farinelli M, Nuvolone M, Mirante O, Moos R, Falsig J, Mansuy IM, Aguzzi A. Prion protein and Abeta-related synaptic toxicity impairment. EMBO Mol Med2010; 2:306-14; PMID:20665634; http://dx.doi.org/10.1002/emmm.201000082
104. Béland M, Motard J, Barbarin A, Roucou X. Pr P(C) homodimerization stimulates the production of Pr PC cleaved fragments Pr PN1 and Pr PC1.J Neurosci2012; 32:13255-63; PMID:22993441; http://dx.doi.org/10.1523/JNEUROSCI. 2236-12.2012
105. Nieznanski K, Choi JK, Chen S, Surewicz K, Surewicz WK. Soluble prion protein inhibits amyloid- (A) fibrillization and toxicity.J Biol Chem2012; 287:33104-8; PMID:22915585; http://dx.doi.org/10.1074/jbc.C112.400614
106. Fluharty BR, Biasini E, Stravalaci M, Sclip A, Diomede L, Balducci C, La Vitola P, Messa M, Colombo L, Forloni G, et al.An N-terminal fragment of the prion protein binds to amyloid- oligomers and inhibits their neurotoxicity in vivo.J Biol Chem2013; 288:7857-66; PMID:23362282; http://dx.doi.org/10.1074/jbc. M112.423954
107. Ostapchenko VG, Beraldo FH, Guimarães AL, Mishra S, Guzman M, Fan J, Martins VR, Prado VF, Prado MA. Increased prion protein processing and expression of metabotropic glutamate receptor 1 in a mouse model of Alzheimer's disease.J Neurochem2013; 127:415-25; PMID:23651058; http://dx.doi.org/10.1111/ jnc.12296
108. Altmeppen HC, Puig B, Dohler F, Thurm DK, Falker C, Krasemann S, Glatzel M. Proteolytic processing of the prion protein in health and disease.Am J Neurodegener Dis2012; 1:15-31; PMID:23383379
109. Liang J, Kong Q. -Cleavage of cellular prion protein. Prion2012; 6:453-60; PMID:23052041; http:// dx.doi.org/10.4161/pri.22511
110. Mc Donald AJ, Dibble JP, Evans EG, Millhauser GL.A New Paradigm for Enzymatic Control of -Cleavage and -Cleavage of the Prion Protein.J Biol Chem2014; 289:803-13; PMID:24247244; http://dx.doi.org/10.1074/jbc.M113.502351
111. Wik L, Klingeborn M, Willander H, Linne T. Separate mechanisms act concurrently to shed and release the prion protein from the cell.Prion2012; 6:498-509; PMID:23093798; http://dx.doi.org/10.4161/ pri.22588
112. Walmsley AR, Watt NT, Taylor DR, Perera WS, Hooper NM. alpha-cleavage of the prion protein occurs in a late compartment of the secretory pathway and is independent of lipid rafts.Mol Cell Neurosci2009; 40:242-8; PMID:19056496; http:// dx.doi.org/10.1016/j.mcn.2008.10.012
113. Liang J, Wang W, Sorensen D, Medina S, Ilchenko S, Kiselar J, Surewicz WK, Booth SA, Kong Q. Cellular prion protein regulates its own -cleavage through ADAM8 in skeletal muscle.J Biol Chem2012; 287:16510-20; PMID:22447932; http://dx.doi.org/10.1074/jbc.M112.360891
114. Kojro E, Gimpl G, Lammich S, Marz W, Fahrenholz F. Low cholesterol stimulates the nonamyloidogenic pathway by its effect on the alpha -secretase ADAM 10.Proc Natl Acad Sci U S A2001; 98:5815-20; PMID:11309494; http://dx.doi.org/10.1073/ pnas.081612998 (Pubitemid 32435725)
115. Kojro E, Füger P, Prinzen C, Kanarek AM, Rat D, Endres K, Fahrenholz F, Postina R. Statins and the squalene synthase inhibitor zaragozic acid stimulate the non-amyloidogenic pathway of amyloid-beta protein precursor processing by suppression of cholesterol synthesis.J Alzheimers Dis2010; 20:1215-31; PMID:20413873
116. Harris B, Pereira I, Parkin E. Targeting ADAM10 to lipid rafts in neuroblastoma SH-SY5Y cells impairs amyloidogenic processing of the amyloid precursor protein.Brain Res2009; 1296:203-15; PMID:19679113; http://dx.doi.org/10.1016/j. brainres.2009.07.105
117. Murai T, Maruyama Y, Mio K, Nishiyama H, Suga M, Sato C. Low cholesterol triggers membrane microdomain- dependent CD44 shedding and suppresses tumor cell migration.J Biol Chem2011; 286:1999-2007; PMID:21087933; http://dx.doi.org/10. 1074/ jbc.M110.184010
118. Rushworth JV, Griffiths HH, Watt NT, Hooper NM. Prion protein-mediated toxicity of amyloid- oligomers requires lipid rafts and the transmembrane LRP1.J Biol Chem2013; 288:8935-51; PMID:23386614; http://dx.doi.org/10.1074/jbc. M112.400358
119. Um JW, Kaufman AC, Kostylev M, Heiss JK, Stagi M, Takahashi H, Kerrisk ME, Vortmeyer A, Wisniewski T, Koleske AJ, et al.Metabotropic glutamate receptor 5 is a coreceptor for Alzheimer a oligomer bound to cellular prion protein.Neuron2013; 79:887-902; PMID:24012003; http://dx.doi.org/10.1016/j. neuron.2013.06.036